Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-247550 (Ixabepilone) in Metastatic Gastric Adenocarcinoma
NCT00017056Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Feb 2001
- Primary completion
- Jan 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ixabepilone in gastric adenocarcinoma, sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Objective Response Rate. Started Feb 2001; status: completed.
02
Drugs
ixabepilone
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00017056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00017056.